U.S. Stock News

OTCPK:FNRN
OTCPK:FNRNBanks

First Northern Community Bancorp (OTCPK:FNRN) Margin Strength Challenges Cautious Narratives

First Northern Community Bancorp (FNRN) has wrapped up FY 2025 with fourth quarter revenue of US$20.0 million and EPS of US$0.35, alongside net income of US$6.0 million. Over recent quarters the bank has seen revenue move from US$18.5 million and EPS of US$0.37 in Q3 2025 to US$20.0 million and EPS of US$0.35 in Q4, with earlier 2025 quarters at US$18.5 million and EPS of US$0.33 in Q2, and US$16.5 million and EPS of US$0.22 in Q1. With a trailing net profit margin of 29.2%, these results...
NasdaqGS:LMNR
NasdaqGS:LMNRFood

Limoneira (LMNR) Loss Deepens In Q1 2026 Challenging Profitability Recovery Narratives

Limoneira (LMNR) has kicked off Q1 2026 with revenue of US$18.2 million and a basic EPS loss of US$0.53, alongside a trailing twelve month EPS loss of US$1.28 on revenue of US$143.6 million, setting a cautious tone around profitability. The company has seen quarterly revenue move from US$34.3 million in Q1 2025 to US$18.2 million in Q1 2026, while basic EPS shifted from a loss of US$0.18 to a loss of US$0.53, putting the focus squarely on how efficiently each dollar of sales is translating...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Should MACOM’s New PCIe 7.0 and Optical Lineup at OFC 2026 Reshape MTSI’s AI Narrative?

In March 2026, MACOM Technology Solutions showcased an extensive range of advanced photonics, optoelectronic and copper interconnect solutions at OFC 2026, highlighting products aimed at AI data centers, cloud infrastructure and high-speed networking, alongside announcing industry-first PCIe 7.0–optimized linear equalizer and cross-point switch devices. This combination of cutting-edge optical transmit, PCIe 6.0/7.0 and coherent lite solutions underlines MACOM’s ambition to be a key enabler...
OTCPK:HKHC
OTCPK:HKHCPersonal Products

Horizon Kinetics Holding (OTCPK:HKHC) 400% Earnings Growth Reinforces Bullish Narratives

Horizon Kinetics Holding (HKHC) just posted fresh FY 2025 numbers, with Q3 revenue of US$17.9 million, basic EPS of US$0.39 and net income from continuing operations of US$7.3 million setting the tone for how the year is shaping up. Looking back over recent quarters, revenue has moved from US$13.1 million in Q3 2024 to US$14.7 million in Q4 2024, then to US$19.8 million in Q1 2025 and US$17.9 million in Q3 2025. Over the same period, basic EPS shifted from a loss of US$2.06 in Q3 2024 to...
NasdaqCM:JYNT
NasdaqCM:JYNTHealthcare

Joint (JYNT) Returns To Quarterly Profit Challenging Persistent Loss Narrative

Joint (JYNT) has just posted its FY 2025 third quarter numbers, with revenue of US$13.4 million and basic EPS of US$0.02, alongside trailing twelve month revenue of US$54.2 million and a trailing EPS loss of US$0.01. Over recent quarters the company has seen quarterly revenue move from US$12.6 million in Q3 2024 to US$14.4 million in Q4 2024, then to US$13.1 million, US$13.3 million and now US$13.4 million. Basic EPS has ranged from a loss of US$0.11 in Q2 2024 to a profit of US$0.07 in Q4...
NYSE:KMPR
NYSE:KMPRInsurance

Is Kemper (KMPR) Rebalancing Geographic Risk or Sacrificing Scale With Its Post‑California Shift?

On March 3, 2026, Kemper Corporation’s interim CEO outlined at a Raymond James conference how higher minimum auto liability limits in California have pressured profitability and prompted a recalibration of its auto insurance business. An important takeaway was Kemper’s plan to reduce earnings volatility by shifting growth emphasis toward markets such as Florida and Texas, aiming to balance its geographic exposure. Next, we’ll examine how Kemper’s push to grow beyond California could...
NasdaqCM:PRQR
NasdaqCM:PRQRBiotechs

ProQR Therapeutics Q4 Net Loss Of €8.9 Million Reinforces Profitability Concerns

ProQR Therapeutics (NasdaqCM:PRQR) has wrapped up FY 2025 with fourth quarter revenue of €4.7 million and a basic EPS loss of €0.08, alongside a net income loss of €8.9 million. These figures put hard numbers around where the business stands today. Over recent periods the company has seen quarterly revenue range from €2.9 million to €4.7 million, while quarterly basic EPS has moved between a loss of €0.12 and a loss of €0.08. As a result, the story for investors remains centered on how...
NasdaqCM:SKIN
NasdaqCM:SKINPersonal Products

Beauty Health (SKIN) Losses Narrow In Q4 Yet Forecast Earnings Declines Challenge Bullish Narratives

Beauty Health (SKIN) closed FY 2025 with fourth quarter revenue of US$82.4 million and a basic EPS loss of US$0.06, alongside trailing twelve month revenue of US$300.8 million and a basic EPS loss of US$0.08. The company has seen quarterly revenue move between US$69.6 million and US$83.5 million over the recent periods. Basic EPS has ranged from a profit of US$0.16 per share in Q2 2025 to losses of around US$0.08 to US$0.15 per share in other quarters, setting up a mixed picture for margins...
NasdaqCM:VFF
NasdaqCM:VFFFood

Village Farms International (VFF) Profitability Turnaround Tests Bullish Margin Narratives

Village Farms International (NasdaqCM:VFF) has just wrapped up FY 2025 with fourth quarter revenue of US$49.6 million and basic EPS of US$0.02, capping a year in which trailing twelve month EPS reached US$0.19 on revenue of US$215.9 million. Over the past few quarters, the company has seen quarterly revenue move from US$39.7 million in Q1 2025 to US$66.7 million in Q3 2025 before settling at US$49.6 million in Q4, while quarterly EPS shifted from a loss of US$0.02 in Q1 to US$0.09 in both Q2...
NasdaqGS:ZUMZ
NasdaqGS:ZUMZSpecialty Retail

Zumiez (ZUMZ) Q4 Profitability Rebound Tests Bullish Margin Expansion Narrative

Zumiez (ZUMZ) closed FY 2026 with fourth quarter revenue of US$291.3 million and basic EPS of US$1.22, alongside net income of US$19.6 million, setting up a cleaner finish to a choppy year. The company has seen quarterly revenue move from US$184.3 million in Q1 to US$291.3 million in Q4, while EPS swung from a loss of US$0.79 in Q1 to a profit of US$1.22 in Q4, giving investors a clearer read on how margins are shaping up across the year. See our full analysis for Zumiez. With the latest...
NYSE:TMHC
NYSE:TMHCConsumer Durables

Is Taylor Morrison Home (TMHC) Still Attractive After Recent Share Price Weakness

If you are wondering whether Taylor Morrison Home's share price still offers value after a strong multi year run, this article walks through what the current market price really implies. The stock closed at US$59.20, with returns of negative 3.3% over the past week and negative 9.9% over the past month, while longer term returns sit at 0.6% year to date, 0.9% over 1 year, 66.5% over 3 years and 97.9% over 5 years. Recent headlines around Taylor Morrison Home have focused on the broader US...
NasdaqCM:RPID
NasdaqCM:RPIDLife Sciences

Rapid Micro Biosystems (RPID) Margin Pressure Persists As Q4 Loss Deepens Despite Revenue Gain

Rapid Micro Biosystems (RPID) just posted its FY 2025 results with Q4 revenue of US$11.3 million and a basic EPS loss of US$0.28, alongside a Q4 net loss of US$12.5 million. The company has seen quarterly revenue move from US$8.2 million in Q4 FY 2024 to US$11.3 million in Q4 FY 2025. Over the same period, basic EPS shifted from a loss of US$0.22 to a loss of US$0.28, and trailing 12 month EPS for Q3 FY 2025 sits at a loss of US$1.00 on net losses of US$44.3 million. For investors, the story...
NYSE:DOUG
NYSE:DOUGReal Estate

Douglas Elliman’s Latest Loss Extends Five Year 54.2% Earnings Decline Narrative

Douglas Elliman (DOUG) has posted another loss for FY 2025’s third quarter, with revenue of US$262.8 million and a basic EPS loss of US$0.29, alongside net income excluding extra items of a US$24.7 million loss. Over recent periods, the company has seen revenue move from US$285.8 million in Q2 2024 to US$266.3 million in Q3 2024, then to US$271.4 million in Q2 2025 and US$262.8 million in Q3 2025. EPS shifted from a US$0.02 loss in Q2 2024 to a US$0.33 loss in Q3 2024, a US$0.27 loss in Q2...
NasdaqCM:WHWK
NasdaqCM:WHWKBiotechs

Whitehawk Therapeutics (WHWK) Swings To US$0.37 EPS Profit Challenging Bearish Turnaround Skepticism

Whitehawk Therapeutics (WHWK) has opened FY 2025 with first half revenue of US$7.1 million and Basic EPS of US$0.37, following a FY 2024 second half that saw revenue of US$14.5 million and a loss per share of US$1.14. Over the past year, the company has moved from Basic EPS of a US$2.36 loss on US$26.0 million of trailing twelve month revenue to a US$0.33 loss on US$7.1 million of trailing twelve month revenue, giving investors a clearer read on how its earnings profile and margins are...
NYSE:GFR
NYSE:GFROil and Gas

Greenfire Resources (NYSE:GFR) Quarterly Loss Challenges Bullish Margin Improvement Narrative

Greenfire Resources (NYSE:GFR) has just posted its FY 2025 third quarter numbers, with revenue of C$136.6 million and a basic EPS loss of C$0.12, set against trailing twelve month revenue of C$655.8 million and basic EPS of C$1.93. Over recent periods, the company has seen quarterly revenue move from C$209.5 million in Q2 2024 to C$201.8 million in Q4 2024, then to C$176.8 million in Q1 2025 and C$140.6 million in Q2 2025, while basic EPS shifted from C$0.45 in Q2 2024 to C$1.13 in Q4 2024,...
NYSE:SRFM
NYSE:SRFMAirlines

Surf Air Mobility (SRFM) Quarterly Loss Of US$27 Million Tests Long Term Growth Narrative

Surf Air Mobility (SRFM) just posted its FY 2025 third quarter numbers, with revenue at US$29.2 million and a basic EPS loss of US$0.64, while trailing twelve month figures show revenue of US$108.2 million and a basic EPS loss of US$3.00. The company has seen quarterly revenue range between US$23.5 million and US$32.4 million across the last six reported periods, with basic EPS moving between a loss of US$24.20 and a small profit of US$0.08. This sets up a story where investors are weighing...
NasdaqGS:KRT
NasdaqGS:KRTTrade Distributors

Karat Packaging (KRT) Dividend Strain Tests Bullish Earnings Growth Narrative

Karat Packaging (KRT) just wrapped up FY 2025 with Q4 revenue of US$115.6 million, basic EPS of US$0.34 and net income of US$6.8 million, while trailing 12 month figures came in at revenue of US$467.7 million, EPS of US$1.57 and net income of US$31.5 million. The company has seen quarterly revenue move from US$101.6 million in Q4 2024 to US$115.6 million in Q4 2025, with basic EPS shifting over the same period from US$0.28 to US$0.34. Investors are now weighing those headline numbers against...
NYSE:EGY
NYSE:EGYOil and Gas

VAALCO Energy Q4 Loss And TTM Turn To Red Test Bullish Profitability Narratives

VAALCO Energy (EGY) closed FY 2025 with Q4 revenue of US$91.0 million and a basic EPS loss of US$0.56, compared with Q4 FY 2024 revenue of US$121.7 million and basic EPS of US$0.11. Over the past year, the trailing twelve month figures moved from revenue of US$479.0 million and basic EPS of US$0.56 at Q4 FY 2024 to revenue of US$359.3 million and a basic EPS loss of US$0.40 by Q4 FY 2025. This sets a challenging backdrop for margins and profitability as investors weigh the company’s...
NasdaqCM:VUZI
NasdaqCM:VUZIElectronic

Vuzix (VUZI) Quarterly Losses Near US$7 Million Reinforce Bearish Cash Burn Narrative

Vuzix (VUZI) has put out its latest FY 2025 numbers with Q3 revenue of about US$1.2 million and a basic EPS loss of US$0.10, alongside a trailing 12 month EPS loss of roughly US$0.49 on revenue of US$5.3 million. Over recent quarters the company has seen revenue move between about US$1.1 million and US$1.6 million while quarterly basic EPS losses have ranged from roughly US$0.10 to US$0.16. As a result, investors may focus less on top line swings and more on how much cash is being burned to...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott Ties Sports Campaign And Mexico Resorts To Future Bookings

Marriott International (NasdaqGS:MAR) has launched its "Where Gameday Checks In" campaign tied to NCAA March Madness and FIFA events. The campaign features high profile athletes and aims to connect Marriott Bonvoy more closely with U.S. sports culture and major global tournaments. In parallel, the company is renovating resorts and adding new all inclusive experiences in Mexico, including properties in Riviera Nayarit and Puerto Vallarta. For you as an investor, this update sits at the...
NYSE:SCHW
NYSE:SCHWCapital Markets

A Look At Charles Schwab’s Valuation As Client Activity Surges And New APIs Gain Traction

Why Schwab’s surging client activity and new APIs matter for investors Charles Schwab (SCHW) is back in focus after its Schwab Trading Activity Index posted the largest monthly gain since late 2020. This comes alongside new API tools that simplify advisory account openings and signal deeper digital engagement. See our latest analysis for Charles Schwab. Schwab’s recent client activity and API rollout come after a period where the 1 year total shareholder return of 22.17% contrasts with a year...
NasdaqCM:TOI
NasdaqCM:TOIHealthcare

Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts

Oncology Institute (TOI) closed out FY 2025 with Q4 revenue of US$142.0 million and a basic EPS loss of US$0.07, while trailing twelve month figures show revenue of US$502.7 million and a net loss of US$60.6 million. The company has seen quarterly revenue move from US$100.3 million in Q4 2024 to US$142.0 million in Q4 2025, with basic EPS losses ranging from US$0.21 in Q1 2025 to US$0.07 in Q4, presenting a picture in which top line scale is increasing while margins remain clearly...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Ulta Beauty (ULTA) Margin Compression Challenges Bullish Growth Narratives After FY 2026 Results

Ulta Beauty (ULTA) has capped FY 2026 with fourth quarter revenue of US$3.9b and basic EPS of US$8.05, alongside net income of US$356.7m, while full year trailing revenue sits at US$12.4b and EPS at US$25.72. The company has seen quarterly revenue move from US$3.5b and EPS of US$8.50 in Q4 FY 2025 to US$3.9b and EPS of US$8.05 in Q4 FY 2026, with comparable sales for the latest quarter at 5.8% and trailing twelve month same store sales growth at 5.4%. With net income over the last twelve...
NasdaqGS:CALM
NasdaqGS:CALMFood

How Analyst Expectations For a Revenue Drop at Cal-Maine (CALM) Have Changed Its Investment Story

Cal-Maine Foods, Inc. recently highlighted its position as the largest U.S. egg producer and scheduled the release of its fiscal 2026 third-quarter results, alongside a management webcast that has now taken place. At the same time, a sharp contrast has emerged between the company’s historically strong revenue growth and analysts’ expectations for a very large revenue decline over the next year. We’ll now examine how concerns about a very large potential revenue drop interact with Cal-Maine...